Categories
news

AEL Files Amicus Brief in Supreme Court Case Relating to Sentencing Reductions

AEL and FAMM File Amicus Brief in Rutherford v. United States

On February 21, 2025, Abell Eskew Landau LLP and FAMM filed an amicus brief in the United States Supreme Court in Rutherford v. United States.  The brief urged the Supreme Court to grant a petition for certiorari filed by Daniel Rutherford, who had sought a sentence reduction in the lower courts pursuant to 18 U.S.C. § 3582(c)(1)(A) (sometimes called the “compassionate release” statute). The district court denied relief and the United States Court of Appeals for the Third Circuit affirmed, holding that a policy statement promulgated by the United States Sentencing Commission in 2023 permitting certain people to seek sentence reductions exceeded the broad authority that Congress expressly delegated to the Commission.     

The brief supports Petitioner’s argument that the Commission’s policy statement, U.S.S.G. § 1B1.13(b)(6), was valid, proper, and within the scope of the Commission’s authority.  Section 1B1.13(b)(6) provides that, when deciding whether a person has identified an extraordinary and compelling reason for a sentence reduction, courts may consider a later change in the law if the person has already served ten years of “an unusually long sentence” that, after full consideration of the person’s individualized circumstances, reflects “a gross disparity” between the sentence being served and the sentence likely to be imposed today. The Third Circuit’s decision reignites a division among the federal Courts of Appeals that § 1B1.13(b)(6) properly resolved, and it prevents many incarcerated people from even seeking to reduce lengthy sentences now acknowledged as unjust. The brief urges the Court to grant the petition in order to confirm the statutory authority of the Commission, the broad scope of courts’ sentencing discretion, and the relevance of changes in the law to motions seeking relief under § 3582(c)(1)(A).

The brief, which can be reviewed below, reflects the firm’s commitment to seeking justice in sentencing and advocating for the rights of incarcerated persons.

The AEL team includes Jarrod Schaeffer, Jeffrey Braun, Katherine Kulkarni, and Olivia Jecklin. The FAMM team includes Mary Price and Shanna Rifkin.

Categories
news

AEL Gets Probation for Pharmacist Client in Healthcare Fraud Case

AEL attorneys David M. Eskew and Heather Suchorsky obtained a probationary sentence (no jail time) in a federal healthcare fraud case on behalf of a pharmacist client. The case, which had been indicted in the Eastern District of New York, was part of a broader healthcare fraud scheme in which the conspirators allegedly paid kickbacks to obtain over $100 million in pharmacy billings. At the sentencing hearing, the government sought a “Guidelines” sentence of nearly three years’ imprisonment and contested the defendant’s submission regarding his role in the broader conspiracy. AEL won the disputed role enhancement issue and obtained a further downward variance based upon several factors under 18 U.S.C. § 3553(a).

The favorable sentence ended a lengthy ordeal for the client, which included a years’ long investigation and an indictment that had been pending for nearly two years more.

The client described AEL’s work in the case: “I am incredibly grateful for the dedication and skill that AEL brought to my case. Their strategic approach, deep understanding of the law, and unwavering support made all the difference in achieving this outcome. It was a long and difficult journey, but their guidance gave me confidence every step of the way.”

AEL specializes in federal white-collar criminal defense with a particular expertise in parallel criminal and civil investigations involving individual and institutional healthcare clients ranging from doctors, pharmacists, and other healthcare professionals to large national hospital systems, laboratories, life sciences companies, and healthcare adjacent entities. AEL has an established track record of assisting clients in avoiding and minimizing federal charges and pushing back against federal prosecutors and agencies with an evidence-based, detail-oriented approach.

*** The foregoing may constitute attorney advertising and readers are cautioned that prior results do not guarantee future outcomes.

Categories
news

AEL’s Banner 2024 in Review

2024 was yet another banner year for AEL with noteworthy results for our clients, growth in several of our practice areas, and a slew of recognitions and honors. We are proud to share just some of the highlights from a truly memorable year at AEL.

Growing Our Team

In 2024, we added to our deep bench of litigators. In January 2024, Jarrod Schaeffer joined AEL as a Partner, Jeff Braun joined as Counsel, and Olivia Jecklin joined as an Associate. Jarrod joined AEL after more than five years as an AUSA in the SDNY where he investigated and prosecuted cases involving corruption, fraud, and international money laundering. Jeff joined AEL following many years at a nationally renowned law firm. Jeff is a highly regarded litigator with broad experience handling commercial and business disputes. Olivia joined AEL from a top-ranked international law firm. AEL also welcomed two new paralegals, Veronica Banat and Charlotte Woods, both recent graduates with exceptional academic credentials. We are incredibly proud of our close-knit team and supportive culture and look forward to announcing more strategic additions to our team in the near future!

Noteworthy Cases and Results

In 2024, AEL continued its well-established track record of getting exceptional results in big cases. Here are just a few examples of our noteworthy results from 2024 and ongoing matters:

False Claims Act and Complex Civil Litigation

  • AEL obtained a civil-only settlement under the False Claims Act on behalf of a nursing home system that owned and operated more than a dozen skilled nursing facilities in the New York region and elsewhere. The highly favorable settlement resolved multiyear parallel criminal and civil investigations conducted by the U.S. Attorney’s Office for the Northern District of New York and the New York Attorney General’s Office. The case was handled by Ken Abell, Scott Glicksman, and Raquel Frier.
  • AEL resolved a pending qui tam action in the Southern District of New York on behalf of a New York-based cardiologist who was previously convicted of criminal charges in connection with a billing issue. The case was handled by Ken Abell, Jarrod Schaeffer, and Kate Kulkarni.
  • AEL procured the voluntary dismissal of all claims brought against multiple clients as part of a sprawling, multimillion dollar civil RICO action filed in New York federal Court. The case was handled by Scott Landau, Jarrod Schaeffer, and Jan Jorritsma.
  • AEL represents the Chief Executive Officer of a large laboratory company in an intervened qui tam action in the Southern District of New York. The client provided institutional and mobile COVID-19 testing services in New York and beyond during the height of the pandemic. The case is being handled by Scott Landau, David Eskew, Scott Glicksman, and Olivia Jecklin.
  • AEL represents the former Chief Executive Officer of a clinical laboratory in a declined qui tam action in the Eastern District of New York. The client’s laboratories provided services to medical practices and skilled nursing facilities. The case is being handled by Scott Landau and Scott Glicksman.
  • AEL represents a major hospital system in a declined qui tam action pending in the District of New Jersey. The client operated joint ventures regarding skilled nursing care that are alleged to have violated the federal Antikickback Statute. The case is being handled by Ken Abell, David Eskew, Jan Jorritsma, and Olivia Jecklin.
  • AEL represents a large health technology company in connection with a civil FCA investigation being conducted by the U.S. Attorney’s Office for the Eastern District of New York. The case is being handled by Ken Abell and Olivia Jecklin.

White Collar Criminal and Parallel Investigations

  • AEL is representing Linda Sun, a former public official in the New York State Government, in a significant prosecution in the Eastern District of New York involving alleged violations of the Foreign Agents Registration Act, visa fraud, alien smuggling, and money laundering. The case is being handled by Ken Abell, Jarrod Schaeffer, and Scott Glicksman.
  • AEL represents one of the country’s largest health systems in several ongoing criminal and civil investigations, including matters related to HIPAA, drug diversion, and False Claims Act investigations. Multiple investigations are pending in the Southern and Eastern Districts of New York, which are primarily being handled by Ken Abell, David Eskew, and Scott Landau.
  • AEL negotiated a favorable plea deal and obtained a sentence of probation for a pharmacist indicted in the Eastern District of New York. The probationary sentence constituted a substantial downward variance from a recommended Guidelines range of three years’ imprisonment. The case was handled by David Eskew and Heather Suchorsky.
  • AEL negotiated a favorable plea deal and obtained a sentence of time served for a Russian national in connection with a multimillion dollar computer fraud conspiracy prosecuted in the Eastern District of New York. The case was handled by David Eskew and Heather Suchorsky.  
  • AEL successfully navigated the former owner of multiple pharmacies through plea negotiations and sentencing in a case indicted in the Southern District of New York. AEL negotiated a favorable plea deal and handled the sentencing, at which the client received a meaningful downward variance. The case was handled by David Eskew and Scott Glicksman.
  • AEL obtained a sentence of 60 days’ imprisonment for a client convicted of leading a telecommunications fraud conspiracy. The case was prosecuted by the Southern District of California and then transferred to the Eastern District of New York for sentencing. The case was handled by David Eskew.
  • AEL obtained a substantial downward variance for a physician-client who pleaded guilty in the District of New Jersey to healthcare fraud charges arising from a genetic testing laboratory scheme. The case was handled by David Eskew and Heather Suchorsky.
  • AEL is serving as pool counsel on behalf of a large publicly-traded diagnostic laboratory services company in connection with a parallel investigation being conduct by the U.S. Attorney’s Office for the District of New Jersey. The case is being handled by David Eskew and Heather Suchorsky.
  • AEL is serving as pool counsel to a large national health system in connection with a parallel investigation being conducted by the U.S. Attorney’s Office for the District of New Jersey. The case is being handled by David Eskew.
  • AEL is representing a former employee of a durable medical equipment company who is being prosecuted in the District of New Jersey. The case is being handled by Ken Abell, David Eskew, and Scott Glicksman.
  • AEL represents a large publicly-traded company in connection with an investigation being conducted by the U.S. Attorney’s Office for the District of New Jersey. The case is being handled by David Eskew.

Healthcare Regulatory and Transactional Matters

  • AEL advised a prominent Article 28 diagnostic treatment center (DTC) in connection with a complicated transaction involving the restructuring of its facility lease and associated debts and obligations.    
  • AEL defended a large not-for-profit multispecialty provider in connection with a third-party payor audit and overpayment demand. The payor’s initial overpayment demand was approximately $3.4mm, however, AEL’ convinced the payor that is allegations were baseless. The payor agreed to drop the audit and demand in its entirety and to close the file. The client paid $0 in overpayments.  
  • AEL represented Ambulatory Surgery Centers in equity and asset sale transactions with private equity backed ventures and other provider entities. 
  • AEL advised multiple healthcare providers and “healthtech” ventures in connection with regulatory and compliance questions and issues, including questions regarding HIPAA privacy and security, Antikickback and Stark Law compliance, Medicare conditions of participation, FDA regulatory matters, and New York State healthcare issues.
  • AEL designed OMIG compliant compliance programs for practice groups and HIPAA compliance programs for healthcare providers and healthcare adjacent concerns.
  • AEL advised a medical practice in connection with a data breach incident and associated issues and questions regarding breach notification, mitigation, and exposure. 

Awards, Recognitions and Accolades

In 2024, AEL received deserved recognition for its excellent work. Below are some highlights:

  • In June 2024, AEL was once again ranked by Chambers USA as a leading law firm in Healthcare (NY), Specialist Litigation Firms in White Collar & Government Investigations (NY), and White Collar Crime & Government Investigations (NJ). Ken Abell, David Eskew, Scott Landau and Jeff Braun were all individually ranked in multiple categories.
  • In July 2024, Jarrod Schaeffer was selected to the 2024 Lawdragon 500 X “Next Generation” list.
  • In August 2024, Jarrod Schaeffer was named to Benchmark Litigation’s 40 and Under List.
  • Also in August 2024, Best Lawyers honored Ken Abell, Scott Landau, Scott Glicksman and Raquel Frier as Best Lawyers in Health Care Law. AEL was also ranked as a Best Law Firm in Health Care Law.
  • David Eskew and Jeff Braun were named to the Super Lawyers list. David Eskew was recognized as a Top Attorney in White Collar Criminal Defense. Jeff Braun obtained the honor for the 18th year in a row in the areas of Business Litigation, Land Use & Zoning and Environmental Litigation.
  • Scott Landau became an Adjunct Professor of Law at Brooklyn Law School, where he co-teaches a seminar on Healthcare Regulation. 

We are enormously grateful for our continued success and to our clients who continue to trust us with important and sensitive matters. We are proud to zealously represent their interests and we are looking forward to an even better 2025. Happy New Year to all.

Categories
blog

Recent Changes to Patient Consent and Payment Laws in New York: What Healthcare Providers Need to Know

New York State recently implemented significant changes to patient consent and payment laws that affect healthcare providers across the state. On October 20, 2024, new laws governing patient consent and payment procedures went into effect, prompting healthcare providers in New York to reassess their current practices. These changes, which are aimed at enhancing patient rights and financial transparency, introduce new requirements that impact how healthcare providers obtain patient consent, discuss costs for medical services, and process payments. As a result of these changes, healthcare providers face the challenge of adapting their policies and operations to ensure compliance. The following overview outlines key changes that providers need to be aware of to effectively comply with these new legal requirements.

Treatment and Payment Consents

The new Section 18-c of the Public Health Law requires that healthcare providers obtain patient consent for treatment, procedures, examinations, or other health care services separately from patient consent to pay for such services. This change forces providers to depart from the common practice of obtaining combined patient consent for treatment and payment. Further, Section 18-c stipulates that providers cannot seek patient consent for payment until two conditions are met: first, there must be a discussion about the costs of treatment, and second, the patient must have already received the healthcare services in question. To ensure compliance with this new law, providers may need to implement new patient consent protocols.

Ultimately, by mandating a cost discussion before payment consent, the law promotes price transparency and may help reduce instances of surprise billing. However, it also creates potential new challenges for healthcare providers, who must now deliver services before securing payment consent.

Restrictions on Pre-Authorization and “Cards on File

Section 519-a of the General Business Law introduces restrictions on healthcare providers’ billing practices. Specifically, it prohibits providers from mandating credit card preauthorization or requiring patients to keep a credit card “on file” as a prerequisite for receiving emergency or medically necessary services. As a result, this may lead to more conservative treatment approaches, as providers may be hesitant to perform procedures without upfront payment assurance.

New Patient Credit Card Notification Requirements

Section 519-a also requires that healthcare providers educate patients about the potential risks associated with using credit cards to pay for medical expenses. More specifically, providers must inform patients that they may lose certain state and federal protections related to medical debt when using credit cards. In anticipation of these legal changes, the New York State Department of Health issued guidance regarding the specific content of these patient notifications. Such guidance clarifies that patient notifications should include the following components: (i) medical bills paid by credit card are no longer considered medical debt; (ii) by paying with a credit card, patients are forgoing federal and state protections around medical debt; (iii) protections that patients must acknowledge forgoing include (a) prohibitions against wage garnishment and property liens, (b) prohibition against reporting medical debt to credit bureaus, and (c) limitations on interest rates; and (iv) patients must affirmatively acknowledge forgoing these protections by paying with a credit card.

Limitations on Provider Involvement in Medical Credit Applications & Prohibition on Assisting with Credit Card/Loan Applications

Pursuant to Section 349-g of the General Business Law, providers can no longer complete any portion of a patient’s application for medical credit cards and third-party medical installment loans or otherwise arrange for an application that is not completely filled out by the patient. This restriction may significantly impact how healthcare facilities assist patients in managing their medical expenses.

* * *

These new statutes likely require changes to previously existing workflows and documentation processes among health care providers in New York.  In order to ensure compliance with these legal changes, health care providers should audit their consent forms and payment processes, and stay informed about additional anticipated forthcoming guidance. AEL is continuing to monitor these legal changes.  If you have any questions, please reach out to us and we will be happy to assist.

Categories
news

Best Lawyers® Honors AEL and AEL Attorneys

Best Lawyers® honored AEL and three of its attorneys again this year.

AEL has been recognized again by “Best Lawyers” as a 2025 “Best Law Firm” in the area of Health Care Law. Additionally, four AEL attorneys took home individual honors. Partners Ken Abell and Scott Landau were named “Best Lawyers” in the category of Health Care Law. And associates Scott Glicksman and Raquel Frier were each named “Ones to Watch.”

The Best Lawyers in America list is one of the most reputable and recognized rankings of attorneys across the nation. Those honored on the list are divided by geographic region and practice area(s) and their work undergoes a significant peer review process.

Best Lawyers: Ones to Watch in America recognizes associates and other attorneys who are at earlier stages of their careers for their impressive performance and professional excellence in private practice. Although slightly newer than the traditional The Best Lawyers in America list, Ones to Watch utilizes the same robust peer-review process and methodology.

Categories
blog

NY Public Campaign Funding May Attract Scrutiny From Feds

This article was authored by Jarrod Schaeffer and was originally published in Law360’s Expert Analysis Section on June 4, 2024.

The upcoming elections across New York this year will be the first under the state’s new program, launched back in 2022, that provides public financing for state political campaigns.

Features of that program mirror New York City’s long-standing public financing program, including the provision of public funds to match small-dollar contributions.

Intended to increase average voters’ impact on state campaigns, the program also may open the door for greater scrutiny of state campaign finance violations by federal prosecutors.

Public Financing Programs in New York

Concerns over the influence of money in politics are nothing new, though the landscape has shifted markedly in recent decades. As election spending explodes, large contributions by select contributors may dwarf contributions by small donors. See, e.g., Sarah Fischer, U.S. Political Ad Market Projected to Reach Record $16 billion in 2024, Axios (Dec. 8, 2023), available here; Vanderwalker, et al., Analysis Shows Amplification of Small Donors Under New NY State Public Financing Program, Brennan Ctr. For Justice (Jan. 30, 2023), available here (“Last year, the 200 biggest donors to candidates gave almost $16 million, more than all 206,000 of the state’s small donors of $250 or less put together.”).

This shift stems in part from U.S. Supreme Court decisions cabining campaign finance regulation. See, e.g., How Does the Citizens United Decision Still Affect Us in 2024?, Campaign Legal Center (Jan. 15, 2024), available here (observing that political spending has “become a growing problem” following certain decisions “as each respective election cycle has seen record-breaking amounts of spending”). Rejecting concerns regarding large contributions in politics (See, e.g., New York Voters Support New Public Campaign Finance Program, Data for Progress (Feb. 28, 2023), available here (finding that “about 9 in 10 New York voters believe wealthy donors have more influence on politicians than the average voter wealthy donors have more influence on politicians than the average voter”—a belief that was “widely shared across partisanship, with 91 percent of Democrats, 93 percent of Independents, and 90 percent of Republicans saying the same.”)), the court declared in its 2010 Citizens United v. Federal Election Commission decision that “[i]ngratiation and access … are not corruption.” Citizens United v. Federal Election Commission, 558 U.S. 310, 360 (2010). And it has repeatedly curtailed regulation it believes could limit “gratitude” to large contributors or impede “the political access such support may afford,” as articulated in its 2014 decision in McCutcheon v. FEC. McCutcheon v. Fed. Election Comm’n, 572 U.S. 185, 192 (2014). It was not always this way. For many years, the Supreme Court acknowledged concerns that improper influence could result from large contributions. See, e.g., McConnell v. Fed. Election Comm’n, 540 U.S. 93, 143 (2003), overruled by Citizens United v. Fed. Election Comm’n, 558 U.S. 310 (2010) (acknowledging an “interest in combating the appearance or perception of corruption engendered by large campaign contributions”); Nixon v. Shrink Missouri Gov’t PAC, 528 U.S. 377, 389 (2000)) (observing that the Court has “recognized a concern not confined to bribery of public officials, but extending to the broader threat from politicians too compliant with the wishes of large contributors”); Austin v. Michigan Chamber of Com., 494 U.S. 652, 659 (1990), overruled by Citizens United v. Fed. Election Comm’n, 558 U.S. 310 (2010) (recognizing “that the compelling governmental interest in preventing corruption supports the restriction of the influence of political war chests funneled through the corporate form” (internal quotation omitted)); Fed. Election Comm’n v. Nat’l Conservative Pol. Action Comm., 470 U.S. 480, 497 (1985) (“Elected officials are influenced to act contrary to their obligations of office by the prospect of financial gain to themselves or infusions of money into their campaigns.”).

Public financing programs, like those in New York City and now New York state, are one way to address concerns about the effects of large contributions. While these programs survive, the Supreme Court has kept them on a tight leash. See, e.g., Arizona Free Enter. Club’s Freedom Club PAC v. Bennett, 564 U.S. 721, 754 (2011) (striking down a public financing program but stating that “governments ‘may engage in public financing of election campaigns’ and that doing so can further ‘significant governmental interests,’ such as the state interest in preventing corruption,” so long as such programs comport with the Court’s interpretation of the First Amendment); Davis v. Fed. Election Comm’n, 554 U.S. 724, 741 (2008) (holding that providing “level electoral opportunities for candidates of different personal wealth” is not “a legitimate government objective”).

While a state public financing program was a long time coming (for instance, last year a former co-chair of New York’s Moreland Commission to Investigate Public Corruption noted that the commission had recommended in 2013, among other things, that the state create a small-donor public financing system to help amplify the influence of average New Yorkers in the face of large contributions. Milton L. Williams, Don’t Give Up On Public Campaign Financing, City & State (Apr. 8, 2023), available here), New York City has long maintained a public financing program for municipal elections. See Friedlander, et al., The New York City Campaign Finance Act, 16 Hofstra L. Rev., Issue 2, art. 4 (1988) (noting passage of New York City’s Campaign Finance Act and

observing that “[i]n enacting this law, the city of New York has become the fourth, and largest, major local government to have instituted a mechanism for providing public funds to candidates seeking election to local office in return for the candidates’ agreement to abide by restrictions on contributions and expenditures”). A key feature of that program is the availability of public matching funds. Candidates who agree to abide by certain fundraising restrictions can receive public funds to supplement, in varying amounts, small-dollar contributions from New York City residents.

The goal of the program is to incentivize candidates to finance campaigns by engaging average voters over pursuing substantial sums from special interests. Matching Funds Program: How It Works, N.Y. Campaign Fin. Bd. (2024), available here.

The program is administered and policed by a nonpartisan independent agency called the New York City Campaign Finance Board, or CFB. About the CFB, N.Y. Campaign Fin. Bd. (2024), available here. In 2021, it distributed almost $127 million in matching funds to participating candidates. Honan, et al., Public Spending on 2021 NYC Elections Blew Away Previous Records, The City (Sept. 27, 2022), available here.

In 2020, the New York Legislature authorized the New York State Public Campaign Finance Program (Part ZZZ of Chapter 58 of the N.Y. Laws of 2020 (enacting N.Y. Elec. Law, art. 14, tit. 2), which, among other things, created a state-level funds matching program, and established a state Public Campaign Finance Board, or PCFB, to administer the program in a manner roughly comparable to that of the CFB. N.Y. Elec. Law, art. 14, tit. 2 § 14-207.

The state program went into effect as of Nov. 9, 2022 (Part ZZZ of Chapter 58 of the N.Y. Laws of 2020 (providing, inter alia, that the relevant sections “shall take effect on 11/9/2022 and shall apply to participants in the primary and general elections to be held in 2024”)), making the upcoming primary and general elections in 2024 the first to be conducted under the auspices of the state program.

As of early March, over 300 candidates had signed up for the state program (Press Release, N.Y.S. Pub. Campaign Fin. Bd. (Mar. 1, 2024), available here) which has allocated $100 million to distribute to eligible campaigns. See Alyssa Katz, State Campaigns Are About to Rake in $100 Million of Public Funding — While Also Spending All The Private Money They Want, The City (May 1, 2024), available here (“The new state budget provides $100 million for matching funds, nearly one-third of the total New York City has given candidates in the entire 36-year history of its system.”).

Federal Prosecutors and State Campaign Finance Violations

The state program’s implementation may provide new possibilities for federal prosecutors in New York. Elections are regulated through a complicated patchwork of federal, state and local laws. In some areas, such as election financing activities by foreign nationals, federal laws take precedence. 52 U.S. Code § 30121(a)(1) (providing, inter alia, that “[i]t shall be unlawful for . . . a foreign national, directly or indirectly, to make . . . a contribution or donation of money or other thing of value . . . in connection with a Federal, State, or local election”); see also United States v. Singh, 979 F.3d 697, 710 (9th Cir. 2020) (concluding that Congress has authority to regulate state elections as to foreign nationals pursuant to its broad power to regulate immigration and foreign affairs). In most other areas, however, states police their own elections under state law. See, e.g., Oregon v. Mitchell, 400 U.S. 112, 134–35 (1970) (Black, J.) (invalidating federal laws setting the voting age state and local elections to “save for the States the power to control state and local elections which the Constitution originally reserved to them and which no subsequent amendment has taken from them”).

Federal prosecutors are empowered to pursue offenses against the U.S. (28 U.S.C. § 547(1) (providing that “[e]xcept as otherwise provided by law, each United States attorney, within his district, shall . . . prosecute for all offenses against the United States”)), and are not authorized to enforce state or local statutes that undergird nonfederal campaign finance regulations.

There are, however, ways in which federal criminal charges can arise from violations of state or local campaign finance laws. Often, such charges turn not on state or local rules themselves, but on federal statutes targeting corruption and fraud. The most common examples are the federal crimes of bribery, 18 U.S.C. § 666, and mail or wire fraud, 18 U.S.C. §§ 1341, 1343. This article focuses on the fraud statutes and, unless otherwise indicated, refers collectively to the mail and wire fraud statutes “[b]ecause the mail fraud and the wire fraud statutes use the same relevant language” and courts generally “analyze them the same way.” United States v. Schwartz, 924 F.2d 410, 416 (2d Cir. 1991).

One of the most common ways prosecutors deploy those statutes is the investigation and prosecution of fake or straw donations that are used to obtain public matching funds. Such prosecutions frequently focus on efforts to obtain matching funds (although schemes to obtain matching funds are the focus of this article, they are not the only way in which federal prosecutors can bring charges predicated on violations of state or local laws. Depending on the facts of a particular case, other federal statutes may apply without any connection to public matching funds. See, e.g., 18 U.S.C. § 1952(a), (b) (prohibiting, inter alia, interstate travel with the intent to commit certain state law crimes, including “extortion” and “bribery”); 18 U.S.C. §§ 1956(c)(7)(A), 1961(1)(A) (prohibiting money laundering involving proceeds of specified unlawful activities including, among other things, inter alia, state law crimes of “extortion” and “bribery”); see also infra n. xxiv), because attempting to secure those funds makes public money the “object of [a] fraud,” to quote the Supreme Court’s 2020 decision in Kelly v. U.S. Kelly v. United States, 590 U.S. 391, 402 (2020) (quoting Pasquantino v. United States, 544 U.S. 349, 355 (2005)); see also United States v. Xing Wu Pan, 632 F. App’x 15, 16 (2d Cir. 2016) (upholding fraud convictions based on a straw donor scheme and noting that “the necessary result of the straw donor scheme was injury to the New York City Campaign Finance Board”).

In other words, federal prosecutors bring charges based on straw donor schemes that violate state or local campaign finance laws, not because those laws were broken, but because the scheme sought to “obtain[] money or property” in the form of matching funds “by means of false or fraudulent pretenses, representations, or promises” under Title 18 of the U.S. Code, Sections 1341 and 1343. 18 U.S.C. §§ 1341, 1343.

Conversely, prosecutors typically do not bring fraud charges where conduct merely provides false information — e.g., incorrect names, addresses or contribution amounts — to state or local regulators. See, e.g., Ciminelli v. United States, 598 U.S. 306, 309 (2023) (quoting United States v. Binday, 804 F.3d 558, 570 (2d Cir. 2015)) (holding that traditional property rights do not include allegations that a “scheme denies the victim the right to control its assets by depriving it of information necessary to make discretionary economic decisions”). Other federal statues prohibit altering information in ways that may be relevant to violations of state or local laws. See, e.g., 18 U.S.C. § 1519 (prohibiting the destruction, alteration, or falsification of records related to matters under federal investigation). Additionally, there may be circumstances where providing incorrect information causes inaccurate federal reporting, giving rise to other potential enforcement. See 52 U.S.C. §§ 30104 (imposing certain reporting requirements regarding contributions under the Federal Election Campaign Act), 30109 (providing for enforcement).

While accurate campaign finance information may be important, courts have held that the federal fraud statutes “protect[] only [an] … interest as property-holder, excluding protection of a governmental entity in its capacity as regulator,” as articulated by the

U.S. Court of Appeals for the Second Circuit in its 1989 decision in Corcoran v. American Plan Corp. Corcoran v. Am. Plan Corp., 886 F.2d 16, 20–23 (2d Cir. 1989); accord Cleveland v. United States, 531 U.S. 12, 20–21 (2000) (finding no property interest because “the State’s core concern [wa]s regulatory” where Louisiana law focused on “the importance of public confidence and trust” in licensed activities, ensuring such activities “are conducted honestly and are free from criminal and corruptive elements,” and “include[d] the distinctively sovereign authority to impose criminal penalties for violations of the licensing scheme” (emphasis in original)).

Since they primarily embody an interest in truthful disclosure, nonfederal campaign finance regulations likely serve a function “ancillary to … regulation, not to property,” in the words of the Second Circuit’s 1988 U.S. v. Evans decision. United States v. Evans, 844 F.2d 36, 42 (2d Cir. 1988) (concluding, in a case where defendants were charged with conspiring to provide false documents in order to obtain government approval for contemplated transactions, that the government’s right to control the future alienation of arms was not a property right for federal fraud purposes); see also Schwartz, 924 F.2d at 417 (citing Evans and concluding that “[w]hat was fraudulently obtained . . . was the government’s agreement to allow [] proposed transactions to take place,” which did not qualify as a property right because “[w]hether it chooses to use licenses or blanket rules, the government’s purpose is to control the private use of private property”); United States v. Murphy, 836 F.2d 248, 254 (6th Cir. 1988) (explaining that a state’s “right to accurate information with respect to its issuance of [] permits constitutes an intangible right” outside the scope of the federal fraud statutes).

Past federal prosecutions in New York have targeted fraudulent attempts to obtain matching funds administered by the CFB. For example, in U.S. v. Baldeo, the U.S. Attorney’s Office for the Southern District of New York charged a former New York City Council candidate in 2013 with fraud offenses based on a scheme to obtain matching funds during his 2010 municipal campaign. No. S1 13 Cr. 125 (PAC), 2013 WL 5477373 at *1 (S.D.N.Y. Oct. 2, 2013). Baldeo ultimately was acquitted of all fraud offenses at trial, but convicted of multiple obstruction of justice offenses.

The government alleged that Baldeo had straw donors complete contribution cards with their own identifying information, but provided, or had others provide, money orders or cash to fund the contributions. See id. Those cards allegedly were submitted to the CFB to obtain matching funds. Id.

Until the creation of the state program, there was no comparable federal hook regarding violations of state campaign finance regulations, because no state matching funds were available. That is no longer the case.

Providing public funds to eligible candidates through the state program may broaden federal prosecutors’ purview with respect to state campaign finance violations, since schemes that fraudulently attempt to obtain state matching funds likely seek to “obtain[] money or property” from the PCFB “by means of false or fraudulent pretenses, representations, or promises” in the same way that similar schemes sought to obtain matching funds from the CFB. 18 U.S.C. §§ 1341, 1343.

With millions of dollars in public money on the line (Rebecca C. Lewis, First $3.6 Million in New York Campaign Matching Funds Headed Out the Door, City & State (May 16, 2024), available here (noting that “[t]he fledgling New York Public Campaign Finance Board approved nearly $3.6 million in matching funds to 37 candidates last week in the first round of disbursements”)), federal prosecutors in New York may seek to leverage that possibility to combat perceived fraud or corruption.

Conclusion

As a result of New York’s provision of public funds to state campaigns, federal prosecutors may have new ways to bring charges predicated on violations of state campaign finance laws.

Only time will tell whether prosecutors seek to pursue these avenues, but responsible campaigns should consider taking steps early to avoid drawing undue federal scrutiny, including implementing a robust compliance program that looks for common indicia of straw contributions.

Jarrod L. Schaeffer is a partner at Abell Eskew Landau LLP. He previously served as an assistant U.S. attorney and as a senior member of the Public Corruption Unit in the U.S. Attorney’s Office for the Southern District of New York.

The opinions expressed are those of the author and do not necessarily reflect the views of their employer or its clients. This article is for general information purposes and is not intended to be and should not be taken as legal advice.

Categories
blog

Defense Attys Must Prep For Imminent AI Crime Enforcement

This Article – authored by Jarrod Schaeffer and Scott Glicksman – was originally published on April 4, 2024 in Law360’s Expert Analysis Section. The Law360 version is available here.

Ever since ChatGPT burst onto the scene in November 2022, new tools and applications using artificial intelligence and adjacent technologies have proliferated across multiple industries. See, e.g., Bernard Marr, A Short History of ChatGPT and How We Got to Where We Are Today (Forbes, May 19, 2023), available here.

And while governments and regulators have started implementing frameworks and guardrails for use cases of these technologies, federal criminal enforcement related to or involving AI is still relatively rare. But that may soon change.

Many have commented on how AI might facilitate new kinds of crimes, as well as the use of AI by the U.S. Department of Justice itself to uncover, track and prosecute criminal activity. Some of those efforts will require time and deliberation, such as the evaluation envisioned by the DOJ’s recently launched Justice AI initiative.

But white collar practitioners should also expect to see federal criminal enforcement issues involving AI arise in the near term, including even in pending cases.

DOJ Mobilization Regarding AI

As part of Executive Order No. 14110 on the safe and secure development of AI, issued on Oct. 30, 2023, President Joe Biden directed federal agencies, including the DOJ, to evaluate potential uses and pitfalls of AI. See, e.g., 88 Fed. Reg. 210 at 75191, 75211–75212, §§ 7.1(b)(i)(A)–(C), (F), available here.

General Lisa Monaco signaled that federal criminal law enforcement officials had begun working to implement the president’s directives. Deputy Attorney General Lisa O. Monaco, Remarks at the University of Oxford on the Promise and Peril of AI (Dep’t of Justice Feb. 14, 2024), available here.

Calling AI “a double-edged sword” with perhaps “the sharpest blade yet,” Monaco extolled the technology’s “potential to be an indispensable tool to help identify, disrupt, and deter criminals, terrorists, and hostile nation-states,” while recognizing “that AI can lower the barriers to entry for criminals.” She went on to say that AI was “changing how crimes are committed and who commits them — creating new opportunities for wanna-be hackers and supercharging the threat posed by the most sophisticated cybercriminals.” Id.

To combat those threats, Monaco announced the Justice AI initiative, which, “[o]ver the next six months, … will convene individuals from across civil society, academia, science, and industry to draw on varied perspectives” in order “to understand and prepare for how AI will affect the Department’s mission and how to ensure [it] accelerate[s] AI’s potential for good while guarding against its risks.” Id.

That initiative is expected to provide its findings by the end of this year, and may build on prior work by the DOJ’s existing Disruptive Technology Strike Force.

But Main Justice officials are not the only ones who will have a hand in policing AI misuses. (This article focuses solely on federal criminal law enforcement efforts and does not address civil enforcement efforts undertaken by a variety of by federal and state regulators.) The 94 U.S. attorney’s offices around the country also play important — and, in some cases, leading — roles in addressing new issues and trends in law enforcement. Prosecutors in those offices are unlikely to wait for the DOJ’s overall deliberative process to conclude — in fact, some have already charged cases that target crimes involving AI. See Press Release, Founder of Artificial Intelligence Start-Up Charged With Fraud (Dep’t of Justice, Aug. 15, 2023), available here; see also Press Release, Two Men Charged for Operating $25M Cryptocurrency Ponzi Scheme (Dep’t of Justice, Dec. 12, 2023), available here.

And Monaco’s remarks, combined with recent events, suggest that the DOJ is not asking them to wait.

Likely Areas of Interest for Federal Law Enforcement

Where should practitioners expect to see more immediate efforts targeting AI by federal prosecutors and law enforcement agencies? Considering Monaco’s recent remarks alongside prior clues from DOJ officials — and taking account of modern law enforcement practices and procedures — AI is likely to become an early focus in a few key areas.

First, prosecutors and agents will likely focus on how AI can facilitate the commission of familiar crimes, as well as how prosecutors can deploy existing tools to combat such misuses.

Since AI acts as a powerful force-multiplier for a wide range of activities, federal criminal enforcement tactics developed for traditional offenses may be readily adapted to cases where those offenses are made more serious or effective through AI.

This is where practitioners are most likely to first encounter these issues, whether in pending cases, ongoing compliance reviews or new investigations.

Second, prosecutors and agents will likely focus on areas where AI may enable new kinds of crimes that would not be possible otherwise, such as advanced AI-enabled cyberweapons and other sophisticated national security threats. See, e.g., Staying ahead of threat actors in the age of AI (Microsoft, Feb. 14, 2024), available here (describing how “[c]ybercrime groups, nation-state threat actors, and other adversaries are exploring and testing different AI technologies as they emerge, in an attempt to understand potential value to their operations and the security controls they may need to circumvent.”).

While industry professionals have yet to see examples of this conduct, most expect that it will soon confront law enforcement. See id. Combating these threats is likely to require the development of new law enforcement tools and the recruitment of additional personnel.

Third, prosecutors and agents will almost certainly explore how AI can be used to better uncover, track and prosecute all kinds of criminal activity.

As many attorneys are aware already from personal experience, AI can make aspects of their own practices more effective and efficient through advanced data processing, sophisticated pattern identification, and the automation of rote tasks. Those same benefits may be harnessed by prosecutors and federal agents, including through the use of AI-assisted document and evidence review tools, early versions of which have existed for years in various forms of less advanced technology-assisted review.

Traditional Offenses Utilizing AI

While prosecutors and agents are likely to eventually explore these and other areas, there are several reasons why their efforts may focus first on traditional offenses utilizing AI.

To begin with, focusing on how AI facilitates the commission of familiar offenses requires less expenditure of new resources, because prosecutors and agents can bring to bear the traditional investigatory tools and strategies that they use in other cases.

More drastic adaptations or paradigm shifts, on the other hand, may take longer, because AI is just as new for law enforcement as it is for society. That does not mean big changes will not come — just that they might take longer to have an impact.

More fundamentally, prosecutors are likely to be most comfortable addressing AI misuses through conventional legal frameworks. As Monaco has reiterated, “Fraud using AI is still fraud. Price fixing using AI is still price fixing. And manipulating markets using AI is still market manipulation.” Deputy Attorney General Lisa O. Monaco, Remarks at American Bar Association’s 39th National Institute on White Collar Crime (Dep’t of Justice Mar. 7, 2024), available here.

Prosecutors have a long history of repurposing existing statutes and enforcement tools to combat challenges arising from new technologies. For instance, in U.S. v. Chastain this past year, the U.S. Attorney’s Office for the Southern District of New York — which is often on the front lines of emerging issues — invoked the wire fraud statute, 18 U.S.C. § 1343, first enacted in the 1950s (66 Stat. 722, ch. 879, § 18(a) (July 16, 1952)), to prosecute fraud involving non-fungible tokens (See Press Release, Former Employee of NFT Marketplace Sentenced to Prison in First-Ever Digital Asset Insider Trading Scheme (Dep’t of Justice, Aug. 22, 2023), available here, which have a considerably more recent vintage. See, e.g., Sarah Cascone, Sotheby’s Is Selling the First NFT Ever Minted—and Bidding Starts at $100 (Artnet, May 7, 2021), available here (noting that the first-ever NFT was minted in 2014). More recently, in U.S. v. Austad, the Southern District of New York unsealed charges alleging, among other things, that the defendants “used artificial intelligence image generation tools” to advertise sales of stolen account credentials. U.S. v. Nathan Austad & Kamerin Stokes. See, e.g., Press Release, Two More Men Charged With Hacking Fantasy Sports and Betting Website (Dep’t of Justice, Jan. 29, 2024), available here.

Investigatory and Compliance Considerations

Given the range of traditional offenses where AI may be particularly easy to misuse, practitioners should expect the same ingenuity in investigations and prosecutions going forward.

For example, because AI can be used to quickly generate and distribute cutting-edge deepfakes and other professional-looking content, it might be used to induce fraud victims to purchase nonexistent goods or services through convincing advertising, enable or amplify a scheme to generate false identification materials, facilitate a market manipulation scheme through the dissemination of forged company literature (See, e.g., Brian Fung, U.S. Senators Propose Tough Fines for AI-driven Securities Fraud or Market Manipulation (CNN, Dec. 19, 2023), available here, or sow confusion intended to disrupt the electoral process through AI-generated robocalls. See, e.g., Holly Ramer, Political Consultant Behind Fake Biden Robocalls Says He Was Trying to Highlight a Need for AI Rules (Assoc. Press, Feb. 24, 2024), available here.

In fact, it appears that prosecutors may already have launched new inquiries focused on AI in the context of traditional crimes. In January, for instance, Bloomberg Law reported that “[p]rosecutors have started subpoenaing pharmaceuticals and digital health companies to learn more about generative technology’s role in facilitating anti-kickback and false claims violations.” Ben Penn, DOJ’s Healthcare Probes of AI Tools Rooted in Purdue Pharma Case (Bloomberg, Jan. 29, 2024), available here.

Such developments necessitate additional considerations not only by those responding to federal investigative inquiries, but also by compliance professionals.

As to the former, practitioners responding to subpoenas and other investigatory demands should carefully consider the capabilities of clients’ AI tools, their internal controls or other relevant compliance protocols, and potential misuses that may have prompted an inquiry or stimulate further interest from prosecutors.

Those same considerations are also important for compliance departments and those who develop or utilize AI for valid purposes, as Monaco has explicitly cautioned that prosecutors will assess management of AI-related risks when considering future resolutions of compliance and enforcement matters. Monaco, Remarks at American Bar Association’s 39th National Institute on White Collar Crime, (Dep’t of Justice Mar. 7, 2024), supra.

Implicit in that warning is the possibility that even AI created or utilized for proper purposes can be misused, and that the DOJ expects those who develop or use AI to take preventative measures.

In connection with appropriate investigations or compliance inquiries, practitioners should consider whether AI may have been utilized, regardless of whether the relevant conduct appears technologically sophisticated. Some uses of AI — such as text or code generation — may not be readily apparent, but nonetheless should be carefully evaluated. This is especially important as the public becomes increasingly conversant with widely available tools that have a variety of existing lawful uses, such as generative AI applications that create text and images.

Considerations for Plea Negotiations and Sentencing

The implications of this focus on AI misuses likely will also extend beyond the investigatory phase into plea negotiations and sentencing arguments, as prosecutors are likely to seek increased penalties that reflect any greater harm flowing from AI.

In February, Monaco observed that “[l]ike a firearm, AI can also enhance the danger of a crime,” and “[g]oing forward, where … prosecutors can seek stiffer sentences for offenses made significantly more dangerous by the misuse of AI — they will,” in addition to seeking reforms that provide additional penalties “if … existing sentencing enhancements don’t adequately address the harms caused by misuse of AI.” Monaco, Remarks at the University of Oxford on the Promise and Peril of AI, supra.

Monaco doubled down on this last month at the American Bar Association’s National Institute on White Collar Crime, emphasizing that “[w]here AI is deliberately misused to make a white-collar crime significantly more serious, our prosecutors will be seeking stiffer sentences — for individual and corporate defendants alike.” Monaco, Remarks at American Bar Association’s 39th National Institute on White Collar Crime, (Dep’t of Justice Mar. 7, 2024), supra.

This is a logical place for prosecutors to deploy tools and practices targeting AI misuse. Novel theories may be easier to advance in this context, because prosecutors have a lower burden of proof, evidentiary rules apply less stringently than they do at trial, and many provisions of the U.S. Sentencing Guidelines are intended to encompass a broad range of flexible policy considerations.

And to the extent that plea negotiations incorporate agreements over what enhancements apply, litigation risks for prosecutors regarding new twists on certain enhancements may be significantly reduced.

Practitioners should carefully consider these issues in the context of plea negotiations, while recognizing that prosecutors likely have significant leverage with respect to some traditional guidelines enhancements.

For example, a familiar enhancement for offenses that involved sophisticated means (U.S.S.G. § 2B1.1(b)(10)(C)) has been construed broadly to apply not only where an offense relied on specialized computer knowledge, (United States v. Hatala , 552 F. App’x 28, 30 (2d Cir. 2014) (upholding enhancement where defendant “used his extensive knowledge of computer programming and database systems, as well as self-written codes, to bypass professionally-designed security systems”) but also where an offense involved the use of readily available software. United States v. Calderon , 209 F. App’x 418, 419 (5th Cir. 2006) (rejecting, inter alia, argument that “printing checks using a computer program available for purchase by anyone at a local office supply store . . . did not constitute sophisticated means” because “[e]ven though certain aspects of [the] scheme were not sophisticated, the offense as a whole involved sophisticated means”). Prosecutors may seek to apply this enhancement in cases where an offense was facilitated by AI, even if the actual application used is generally commercially available.

Similarly, enhancements targeting the use of authentication features[25] have been applied to items ranging from forged notary seals (United States v. Sardariani, 754 F.3d 1118, 1122 (9th Cir. 2014)) to voice verification data (See, e.g., United States v. Barrogo, 59 F.4th 440, 446 (9th Cir. 2023) (concluding that an “authentication feature” encompasses “non-physical” means of identification like biometric data, including “voice or retina information”)—all things for which sophisticated AI might generate passable forgeries. See, e.g., Press Release, Gartner Predicts 30% of Enterprises Will Consider Identity Verification and Authentication Solutions Unreliable in Isolation Due to AI-Generated Deepfakes by 2026 (Gartner, Inc., Feb. 1, 2024), available here. Prosecutors may seek to apply these enhancements where AI was used to create deepfakes that circumvent advanced identity authentication measures. Practitioners should carefully consider the application of such guidelines provisions and attempt to anticipate how prosecutors may retool other conventional arguments based on the particular facts of a case. And it is important to consider such issues early in the life of a case, so that practitioners are prepared during plea negotiations that may significantly affect later positions taken at sentencing.

Conclusion

As technologies and applications utilizing AI continue to proliferate and new tools are developed, white collar practitioners should expect to encounter AI in federal criminal enforcement matters sooner rather than later. Even as the DOJ deliberates on an overall approach to AI, prosecutors and agents are likely to forge ahead while repurposing traditional strategies and tools. And because an early focus by those actors is likely to be where the misuse of AI facilitates the commission of conventional offenses, practitioners should carefully consider how clients — even those using or developing AI for lawful purposes, or in existing cases otherwise involving only traditional offenses — may use AI, and the significance it could have for an investigation or prosecution.

Categories
news

AEL Partner Jarrod Schaeffer Interviewed on NPR Regarding Jeffrey Epstein Case

AEL Partner and former federal prosecutor (SDNY) Jarrod Schaeffer was interviewed by NPR’s Leila Fadel regarding the release of additional documents connected to the Jeffrey Epstein case.

The interview, which was featured on WNYC’s Morning Edition, was aired on on January 5, 2024. You can listen and read the full transcript here, or listen to the full audio below.  

Categories
news

AEL Partner Jarrod Schaeffer Quoted in ABC News Article Regarding Upcoming Trump Trial

AEL Partner and former federal prosecutor (SDNY) Jarrod Schaeffer was quoted in a recent article by ABC News regarding the challenges facing both the prosecution and defense lawyers in jury selection in the upcoming Trump “hush money” trial.

The article, which was published on March 11, 2024, is entitled “Attorneys face unprecedented challenge in selecting jury for Trump’s hush money trial.” You can read the full article courtesy of ABC News here.

Categories
news Uncategorized

AEL Adds SDNY Prosecutor Jarrod L. Schaeffer and Prominent Litigator Jeffrey L. Braun to Growing Team

Abell Eskew Landau LLP (AEL), a boutique law firm specializing in white-collar criminal defense, government investigations, commercial litigation, and healthcare regulatory counseling, proudly announces that former Southern District of New York (SDNY) federal prosecutor Jarrod L. Schaeffer and highly regarded commercial litigator Jeffrey L. Braun have joined the firm.

Schaeffer joins AEL as a partner after serving for more than five years as an Assistant U.S. Attorney (AUSA) for the SDNY.  As an AUSA, Schaeffer investigated and prosecuted cases involving corruption, fraud, and international money laundering. Most recently, Schaeffer served as a senior member of the SDNY’s Public Corruption Unit where he handled some of the office’s most sophisticated and sensitive matters, including high-profile investigations and prosecutions of politicians, law enforcement officers, and attorneys. Schaeffer’s hire follows AEL’s addition of Heather Suchorsky, another former federal prosecutor, last year.   

“We are excited to welcome Jarrod to the firm as a partner and senior member of the team,” said David M. Eskew, one of AEL’s three founding partners and himself a former AUSA. “Jarrod is a phenomenal criminal and civil litigator, and with his addition, AEL’s ever-growing bench of talent now includes five former federal prosecutors from the U.S. Attorney’s Offices for the Southern and Eastern Districts of New York and the District of New Jersey, further building upon our already well-recognized capability to handle the most sophisticated and difficult white collar criminal cases in this region.”

“I’m very excited to join Ken, David, Scott, and the growing team at AEL,” said Schaeffer. “In just a few short years, the firm has developed an impressive track record and I look forward to assisting clients in criminal defense and government enforcement matters, as well as in complex commercial and civil litigation.”

Eskew explained the strategic value of the move. “Our white collar criminal defense and government investigations practices have grown substantially over the past few years following some notable successes, including dismissals of charged cases in the SDNY, EDNY and DNJ. As a result, we have been consistently engaged in charged cases and investigations in each of the three big federal districts in the NY/NJ metro area. By adding Jarrod to the team, we bring in a well-respected former prosecutor from SDNY, which was a piece we were previously missing. Now, half of our attorneys are former federal prosecutors and we can boast prior government service and experience in each of the major federal districts in our area. Our firm is already well-known for its expertise in criminal and civil healthcare fraud investigations. With the addition of Jarrod this year and Heather Suchorsky last year, we are poised to expand our reach and expertise in 2024 into other complex fraud cases, including public corruption, financial fraud and money laundering cases.”

Braun, who joins AEL as Counsel, is a highly regarded litigator and counselor with broad experience handling commercial and business disputes. Before joining AEL, Braun spent most of his career as a litigation partner at two national law firms. His practice focuses on complex and often high-profile commercial, real estate, land use, and environmental matters for leading developers, corporations, and nonprofit institutions. Chambers & Co. describes him as “a great litigator with deep experience,” and he was recently ranked number 13 on the New York City and State’s Law Power 100 List honoring lawyers with the biggest impact on New York State.

“Several years ago I had the privilege of working with Jeff on a high-profile land-use case. His skill and expertise handling complex matters led to a resounding victory for our client,” said AEL founding partner Scott R. Landau. “We are thrilled that Jeff is making the jump from ‘big law’ to our boutique law practice, where he will continue to serve clients in high-stakes commercial and real estate matters and will help further grow AEL’s civil litigation practice.”

“Joining a boutique law firm is an exciting change for me, and I’m thrilled to be here,” said Braun. “I was so impressed with Scott when we worked together a few years ago. Ken and David are equally impressive, and AEL has built such a strong team that I am grateful for the opportunity to be part of it.”

* * *

AEL was founded in 2020, just weeks before the global pandemic, by three former federal prosecutors. The firm specializes in white collar criminal defense and government investigations, with a particular focus on federal parallel criminal and civil investigations and cases in the healthcare industry in New York and New Jersey. The firm also handles complex commercial litigation and healthcare regulatory counseling. Since its launch, AEL has achieved consistent growth and has expanded to a team of ten attorneys, including five former federal prosecutors, and focuses on providing practical, no-nonsense, client-centered representation and counsel.

Categories
news

Best Lawyers in America® Honors AEL as a “Best Firm” and AEL Attorneys as “Best Attorneys”

AEL is proud to announce that it has been recognized by “Best Lawyers” as a 2024 “Best Law Firm” in the area of Health Care Law – New York City.  These rankings are based in part on responses and comments from our wonderfully supportive clients, just a few of whose comments are as follows:

  • “Abell Eskew Landau is a small firm with world class expertise and knowledge. They do phenomenal work across a range of healthcare and corporate issues.”
  • “Abell Eskew Landau is an outstanding boutique firm with deeply knowledgeable attorneys in the field of healthcare law. The firm’s team demonstrates a commitment to excellence, value and client service.”
  • “Abell Eskew Landau is an amazing boutique specialty law firm. Very responsive, aggressive but diplomatic and overall, extremely effective.”

This honor follows on the heels of AEL’s recent recognition by Chambers USA as a leading law firm in Healthcare and White Collar Crime & Government Investigations, and its inclusion as a Best Law Firm for Health Care Law by U.S. News and World Report.

In addition, a number of AEL attorneys were individually named to the 2024 lists of Best Lawyers in America. Scott R. Landau was once again recognized as a “Best Lawyer” in the category of Health Care Law, and Scott Glicksman, Kate Kulkarni, and Raquel Frier were all recognized as “Best Lawyers: Ones to Watch in America.” 

About AEL

Abell Eskew Landau (AEL) is a boutique law firm specializing in government investigations and enforcement matters, whistleblower/qui tam cases, white collar criminal defense, regulatory and compliance counseling, sophisticated transactional matters, and complex commercial litigation, with a particular focus on the healthcare industry. Our lawyers have decades of combined experience as federal and state healthcare and white collar fraud prosecutors, as in-house counsel for an academic medical center, and as trusted outside counsel to hospitals and health systems, diagnostic and treatment centers, ambulatory surgery centers, nursing homes, private medical practices, professionals and executives, and healthcare tech startups. We leverage our unique experience to provide expert advocacy and innovative solutions to the most challenging problems faced by our clients. 

About Best Lawyers in America

The Best Lawyers in America list, having been published for more than three decades, is one of the most reputable and recognized rankings of attorneys across the nation. Those honored on the list are divided by geographic region and practice area(s) and their work undergoes a significant peer review process.

Best Lawyers: Ones to Watch in America recognizes associates and other attorneys who are at earlier stages of their careers for their impressive performance and professional excellence in private practice. Although slightly newer than the traditional The Best Lawyers in America list, Ones to Watch utilizes the same robust peer-review process and methodology.

To learn more about the review process utilized by Best Lawyers, please click here.

Categories
news Uncategorized

Case Dismissed: Federal Healthcare Fraud Charges Alleging COVID-19 Lab Testing Kickbacks and Fraud Scheme Dismissed Against AEL Client

AEL attorneys David M. Eskew and Heather Suchorsky obtained dismissal of all federal charges against an AEL client in a case involving allegations by federal prosecutors that the client participated in a fraudulent COVID-19 lab testing conspiracy. This is the third time that AEL has obtained this exceedingly rare result in a criminal case in the past two years (see prior posts here, here, and here). Utilizing an evidence-based approach to refute the charges in the criminal complaint, AEL presented on multiple occasions to the U.S. Attorney’s Office arguing that the charges were factually unsupported and inaccurate. After a lengthy process, AEL convinced federal prosecutors to dismiss all charges against the client.

Regarding AEL’s work on the case, the client offered the following comments:

I am beyond grateful for all of the hard work that David and Heather did on my case. My family feels truly blessed and happy to have found the AEL team and are anxious to put the darkness of these charges behind our family forever. David and Heather exhibited outstanding teamwork, professionalism, responsiveness, diligence and excellence in convincing the government to dismiss the charges against me. The most important thing to me was that David and Heather never wavered in their belief that I was innocent of the charges and fought for me every step of the way based on that belief.

Federal prosecutors initially charged the client and multiple other co-defendants by criminal complaint in early 2022 with conspiracy to violate the federal Antikickback Statute, 42 U.S.C. § 1320a-7(b)(1). The complaint alleged that the co-defendants conspired to pay and receive illegal kickbacks and bribes related to the referral of COVID-19 tests to a NJ-based laboratory. The government incorrectly labeled the client a “marketer” of COVID-19 tests for the laboratory and accused the defendant of accepting bribes in order to refer thousands of COVID-19 tests to the laboratory.

In the two-year period following the charges, AEL worked collaboratively with the client to review extensive evidence showing that the client was the operator of a legitimate mobile COVID-19 testing business and not a marketer for the laboratory. AEL made multiple productions to the government and provided detailed evidence-based presentations. In late 2022, the government returned an indictment against the client’s co-defendants, advancing the case against those individuals, but left AEL’s client off the indictment. In July 2023, federal prosecutors dismissed the charges against AEL’s client in their entirety, ending the case against him.

AEL specializes in federal white-collar criminal defense with a particular expertise in parallel criminal and civil investigations involving individual and institutional healthcare clients ranging from doctors, pharmacists, and other healthcare professionals to large national hospital systems, laboratories, life sciences companies, and healthcare adjacent entities. AEL has an established track record of assisting clients in avoiding and minimizing federal charges and pushing back against federal prosecutors and agencies with AEL’s signature evidence-based, detail-oriented approach.

*** The foregoing may constitute attorney advertising and readers are cautioned that prior results do not guarantee future outcomes.

Categories
news

AEL Negotiates Misdemeanor Resolution of FDA Investigation; Obtains Sentence of Probation

AEL attorneys Ken Abell and Heather Suchorsky successfully steered a federal felony investigation regarding potential criminal violations of the Food Drug and Cosmetic Act (FDCA) to a misdemeanor resolution and a probationary sentence with no fine. Over the course of a lengthy twenty-month period, federal prosecutors and law enforcement agencies in the Eastern District of New York (EDNY) were investigating the client – a Long Island-based import/export wholesale business – for two felonies: distribution of misbranded drugs and smuggling goods into the United States. AEL made several presentations to the EDNY and provided exculpatory information relating to the two felony charges, which led prosecutors to accept a non-intent misdemeanor plea under the FDCA from the client. At sentencing last month, the judge imposed a purely probationary sentence and rejected the imposition of any fine.

The client was comforted by the result and stated the following:

Over a challenging 20-month period, dealing with FDA and trade matters, I had the privilege of being represented by Ken and his excellent team. Ken, with his unending availability and insightful advice, made the entire process more manageable. He was consistently approachable, listened to all of my concerns attentively, and guided me towards the most beneficial solutions. Heather, a member of his team, displayed immense knowledge and demonstrated an impressive readiness[.] The satisfaction and relief I feel today would not have been possible without their expertise and commitment. I wholeheartedly recommend their services, especially to those dealing with FDA-related complexities. They bring experience, professionalism, and most importantly, empathy to their work.

This is not the first time AEL has resolved federal felony charges for a non-intent misdemeanor FDCA offense and a probationary sentence. In 2021, AEL previously secured dismissal of a felony healthcare fraud indictment against a doctor-client who pled guilty to a superseding information charging only the non-intent FDCA offense. The doctor also received a probationary sentence.

AEL specializes in federal white-collar criminal defense with a particular expertise in parallel criminal and civil investigations involving individual and institutional healthcare clients ranging from doctors, pharmacists, and other healthcare professionals to large national hospital systems, laboratories, life sciences companies, and healthcare adjacent entities. AEL has an established track record of assisting clients in avoiding and minimizing federal charges and pushing back against federal prosecutors and agencies with AEL’s signature evidence-based, detail-oriented approach.

Categories
news

AEL Again Ranked by Chambers USA as Top Firm for Healthcare and White-Collar Criminal Defense & Government Investigations

Abell Eskew Landau LLP (“AEL”) is pleased to announce that the Firm and all three of its Partners were once again recognized in the 2023 Chambers USA Guide as a leading law firm and leading attorneys in multiple categories.

In the 2023 Guide, which was released earlier today, Chambers ranked AEL alongside some of the nation’s largest and most prestigious firms in the categories of Healthcare (NY); Litigation: White-Collar Crime & Government Investigations (NJ); and Litigation: Specialist Firms in White-Collar Crime & Government Investigations (NY).

Remarkably, AEL is the only top-ranked law firm in Chamber’s Healthcare (NY) rankings with less than 80 lawyers (AEL has 9) and only one of two law firms with less than 200 lawyers, making AEL a “unicorn” within the legal healthcare market. AEL is a powerhouse healthcare boutique that stands alone in its ability to deliver top-quality healthcare counsel with the unrivaled efficiency and responsiveness of a true boutique law firm.

Indeed, Chambers took particular note of AEL’s “thoughtfulness of approach and efficiency in delivering first-rate results.” With respect to white-collar criminal matters and government investigations, Chambers stated: “AEL has an excellent ability to handle complex white-collar and health regulatory matters.” One client noted, “[t]he Abell Eskew Landau team has terrific experience and a real understanding of how the government works.” Regarding healthcare matters, a client stated that AEL “lawyers have a breadth of experience and they know the subject matter well.”

Chambers also recognized AEL’s partners individually, ranking all three AEL partners as top attorneys for Healthcare (NY) and partner David Eskew as a top lawyer White-Collar Crime & Government Investigations in both NY and NJ. Clients and other attorneys lauded AEL’s partners, describing Scott Landau as “well informed, responsive, and able to clearly explain the risks and benefits of complex legal options in a way that is actionable.” One client described David Eskew as a “real sharp lawyer” and a “strong white-collar practitioner who knows how to interact with judges effectively.” Ken Abell was recognized as “incredibly responsive” and as having “a very strong knowledge of the law,” especially when it comes to “handling complex litigation in the healthcare space.”

AEL’s year-over-year Chambers ranking continues to place it among the nations’ top healthcare Firms, alongside some of the country’s largest and most well-known law firms. Nonetheless, AEL continues to pride itself on being a boutique law firm that specializes in healthcare and white collar parallel criminal and civil cases and government investigations, with a particular expertise in matters involving the False Claims Act (FCA), the Antikickback Statute (AKS), the federal Stark Law, and other healthcare-centric regulatory and enforcement matters. With a growing team of 9 lawyers and 2 paralegals, AEL is capable of handling any matter or client – no matter how large or small – while still maintaining its signature and well-recognized responsive, practical, detail-oriented, evidence-based, and efficient approach.

The complete rankings by Chambers USA appear below:

Abell Eskew Landau

Litigation (NJ) – Band 3

Healthcare (NY) – Band 5

Litigation: Specialist Firms in White-Collar Crime & Investigations (NY) – Band 3

Kenneth M. Abell

Healthcare (NY) – Band 5

David M. Eskew

Healthcare (NY) – Band 5

Litigation: White Collar Crime & Government Investigations (NJ) – Band 3

Litigation: White Collar Crime & Government Investigations (NY) – Band 5

Scott R. Landau

Healthcare (NY) – Band 5

Categories
news

AEL Wins Substantial Downward Variance at Sentencing in High Profile Healthcare Fraud Case

New York, NY — On March 23, 2023, AEL secured a below-Guidelines sentence for its client, a NYC-based pain management physician who previously pled guilty for his role in an alleged fraud scheme in the Southern District of New York. As part of his negotiated guilty plea, he faced a maximum 10-year sentence and Guidelines range of 70 to 87 months. At the sentencing hearing, the Government sought a Guidelines sentence despite the presence of several mitigating factors.

The multi-defendant case–implicating a group of lawyers, doctors, and a litigation financier, among others–involved an alleged conspiracy to defraud businesses and insurance companies through the staging of accidents and unnecessary medical procedures to support fraudulent legal claims. At the sentencing hearing and in its sentencing memorandum, AEL argued that its client’s intent and conduct were substantially and meaningfully different from that of other members of the conspiracy, some of whom had already been convicted in a previous trial and sentenced to as much as 72 months in prison. AEL asked the Court to consider various mitigating factors relating to its client’s offense conduct and personal history and circumstances, urging the Court to impose a sentence of probation or in the alternative, a far lower custodial term than was called for by the Guidelines and sought by the Government. On behalf of its client, AEL submitted 77 letters from friends, family members, colleagues, and former patients to demonstrate that he was a generous and selfless person of extraordinary character.

After a 2-hour sentencing hearing and as a result of AEL’s arguments, the Court imposed a sentence of 36 months’ imprisonment, far below the terms received by defendants previously sentenced, nearly half of the applicable Guidelines range, and far lower than the sentence sought by the prosecutors. “Though the Court imposed a custodial sentence, we are grateful that the court took into account several factors that we asked it to consider,” said AEL partner Kenneth M. Abell in a press statement. AEL’s client “appreciates the careful consideration the court put into crafting its sentence and accepts and respects the judge’s decision.”

“From the outset, the team at AEL (Ken, Scott and Nora) treated me with dignity and respect,” said the client. “They never judged me for the decisions I made and instead focused on getting the best possible outcome.  They did a lot of hard work, learned the details of my case, negotiated a good plea agreement with the government and drafted a sentencing memorandum that explained my specific situation to the judge.  They also obtained permission for me to travel to Brazil for health and family reasons on three separate occasions after I was arrested. The sentence I ultimately received was far less than the government was seeking and I have the team at AEL to thank for that.  I’m forever grateful for their diligence, compassion and professionalism.”

The highly-publicized case, handled by partner Kenneth M. Abell, associate Scott Glicksman and paralegal Nora Maetzener, was covered by Law360 as well as various regional, national, and international news outlets.

For select coverage, see the following:

AEL has a robust white collar criminal defense practice that focuses on complex fraud investigations and prosecutions, with a particular expertise in healthcare and government fraud, securities fraud, bank and wire fraud, money laundering, and computer fraud. AEL also specializes in parallel criminal and civil investigations and cases, whistleblower/qui tam defense, and False Claims Act (FCA) and Antikickback Statute (AKS) cases. Partners Ken Abell and David M. Eskew lead the Firm’s White Collar Criminal Defense and Government Investigations and Enforcement Defense Practice Areas.

* This post contains attorney advertising. Prior results do not guarantee similar outcomes.

Categories
news

AEL Doctor Client Sentenced to Probation; Retains Medical License; Receives Return of Large Portion of Seized Assets

Brooklyn, New York – On February 15, 2023, a Kings County Judge sentenced an AEL client – a radiologist based on Long Island, New York – to a sentence of probation. As part of the global resolution of the charges, the Kings County District Attorney’s Office also agreed to release its restraints on the client’s home, car, and over approximately $1 million in assets held in nearly two dozen bank, credit and brokerage accounts. AEL also negotiated for the doctor to retain his medical license pursuant to the terms of a Consent Agreement that was negotiated with the New York Office of Professional Medical Conduct (OPMC) in conjunction with the entry of the client’s plea in this matter.

This global resolution and probationary sentence resolved a years’ long multi-defendant criminal case that began in 2017 and straddled (and was repeatedly delayed by) the COVID-19 pandemic. The client was originally charged in a sweeping 34-defendant, 878-count indictment that alleged, among other things, a $146 million healthcare fraud scheme. The client emphatically denied his involvement in the broader enterprise corruption conspiracy charged in the complaint and consistently maintained that he endeavored to improve the alleged conspirators’ medical practices rather than joining in a conspiracy with them. Over the course of many years, with the assistance of and in collaboration with the client, AEL succeeded in whittling away the State’s case and proofs. In December 2022, after extensive negotiation amongst the DA’s Office and AEL, the client pled guilty to a single count of healthcare fraud in the third degree – a lesser included offense of one of the counts of the indictment – admitting that he had wrongfully received in the aggregate more than just $10,000 from a single health plan. The parties stipulated to a probationary sentence, a $400,000 forfeiture, release of the remaining restraints on the client’s property, including the client’s home and more than $1 million in assets, and the maintenance of the client’s medical license.

The case was handled by AEL partner David M. Eskew and associate Julia H. Sear.  

AEL prides itself on its evidence-based approach to its defense of white-collar criminal and complex fraud cases and its particular expertise in achieving global resolutions in parallel criminal and civil investigations and cases that threaten not only criminal and civil penalties, but administrative and professional licensing issues as well.

Categories
news

U.S. News Honors AEL as a 2023 Best Law Firm for Health Care Law

On November 3, 2022, U.S. News & World Report announced that it had selected AEL as a Best Law Firm for Health Care Law in New York. According to U.S. News & World Report, “[a]chieving a tiered ranking in U.S. News – Best Lawyers “Best Law Firms” signals a unique combination of quality law practice and breadth of legal expertise. Ranked firms, presented in three tiers, are recognized on a national and regional-based scale. Firms that received a tier designation reflect the highest level of respect a firm can earn among other leading lawyers and clients from the same communities and practice areas.”

AEL is extremely proud to be a leader in representing and advocating for health care concerns. In the past year, AEL has advised clients of all sizes – from publicly-traded companies to individuals – on healthcare regulatory matters; healthcare transactions; parallel criminal and civil investigations arising under the federal False Claims Act (FCA), the Antikickback Statute (AKS), HIPAA, the “Stark Law,” and other federal and state statutes; white collar criminal cases involving doctors, pharmacists, and other medical professionals; and in high stakes commercial litigation. AEL’s lawyers have been qualified as experts by courts and tribunals in the areas of parallel investigations, the FCA, the AKS, and EKRA. Earlier this year, AEL was recognized by Chambers & Partners in the areas of Health Care Law and White Collar Criminal Defense and Government Investigations.

Categories
news

Former DNJ Federal Prosecutor Joins AEL

AEL is thrilled to announce that former federal prosecutor Heather Suchorsky, who spent five years in the U.S. Attorney’s Office for the District of New Jersey as a white-collar and gangs prosecutor, has joined Abell Eskew Landau LLP (AEL) as Of Counsel. Since its launch in 2020, AEL has become known as experts within the healthcare legal market and has built a thriving practice representing healthcare institutions, healthcare-adjacent technology companies, and healthcare professionals in federal and state investigations, civil enforcement matters, criminal cases, and insurance disputes. With the addition of Ms. Suchorsky, AEL expands its rapidly growing New Jersey practice and augments its expertise in the areas of securities fraud, bank fraud, and mortgage fraud cases.

Over the past three years, AEL’s partners Ken Abell, David Eskew and Scott Landau have built a well-rounded full-service healthcare law firm representing institutions and individuals, from publicly-traded companies and prominent hospital systems to local labs, medical practices, start-ups, and individual doctors and medical professionals. AEL has been recognized by Chambers & Partners as a top firm for both Healthcare and White Collar Crime and Government Investigations and each of AEL’s partners have been individually ranked. As recognized by Chambers, the Firm has experienced a “meteoric rise” and is already “one of the top-tier groups for healthcare and white-collar matters[.]” In the past three years, AEL has added four associates and two paralegals and built out an office space on Fifth Avenue in Manhattan.

With the addition of Heather Suchorsky, AEL adds to its deep bench of experienced federal practitioners. “Heather was among the finest AUSAs in the District of New Jersey, respected for her intelligence, work ethic, trial acumen and fairness,” said AEL partner David M. Eskew. “She brings to the Firm extensive trial experience and deepens our capabilities in the defense of financial crimes, including securities fraud, bank and wire fraud, and mortgage fraud. Perhaps more importantly, Heather adds another dimension to our Firm’s leadership and we are thrilled to welcome her.”

Heather served as a federal prosecutor in the U.S. Attorney’s Office for the District of New Jersey from 2017 to 2022. Most recently, she served in the Office’s Economic Crimes Unit, which handles complex financial crimes. Before that, Heather served in the Organized Crime and Gangs Unit where she specialized in the investigation and prosecution of violent organized street gangs. Before her time as a federal prosecutor, Heather clerked for the Honorable Kevin McNulty, U.S. District Judge for the District of New Jersey and worked at a large international law firm. She is a graduate of the University of Pennsylvania Law School, magna cum laude, and the University of Pennsylvania College of Arts & Sciences, summa cum laude.   

Categories
news Uncategorized

AEL Wins Appellate Victory for Hospital System

AEL’s streak of successful appellate victories continues with our recent victory on behalf of clients Mount Sinai Health System (“MSHS”), South Nassau Communities Hospital (“SNCH”), and South Nassau Medical Group, P.C. (“SNMG”) in South Nassau v. 105 Rockaway Realty, LLC, a dispute regarding the terms of a lease for commercial office space in a building in the Rockaways in Queens. Scott R. Landau and Kenneth M. Abell represented MSHS, SNCH, and SNMG in this matter. 

In this case, the parties disputed whether SNMG owed any responsibilities under a lease given that an express condition precedent in the lease had not occurred. Specifically, the lease had expressly conditioned SNMG’s obligations thereunder on SNCH “obtaining, on terms acceptable to it,” an equity ownership in a certain Ambulatory Surgery Center (“ASC”) that was to be established in the same building. Though it was undisputed that the condition had not actually occurred, the landlord claimed that SNMG could not use the failure of the condition as a basis for “escaping” its obligations because satisfaction of the condition was within the control of its affiliate, SNCH. The landlord also asserted a claim against MSHS, which had later become the parent of SNCH, for tortious interference with contract, alleging that it had “directed” South Nassau not to invest in the ASC.

Given the plain and express language of the condition precedent, we moved for pre-discovery summary judgment seeking a declaration that SNMG did not have responsibilities under the lease because the condition precedent did not occur. Following the trial court’s granting summary judgment (and dismissing the landlord’s tortious interference claim against MSHS), the landlord appealed, arguing that there were open questions of fact regarding whether SNMG and SNCH had sufficiently negotiated to invest in the ASC, and that reversal and remand was accordingly required for discovery into whether they had violated the implied covenant of good faith and fair dealing implicit in the lease. 

On August 24, 2022, the Second Department rejected the landlord’s appeal and affirmed the trial court’s decisions. In so ruling, the Second Department agreed with our argument that the six (6) word condition precedent in the lease contemplated the exercise of discretion by SNCH/SNMG, and thus that that the obligations the landlord sought to imply into the lease were inconsistent with the actual terms of that agreement. The court thus held that the questions of fact raised by the landlord were not actually material, and that reversal and remand was thus not necessary because there was no dispute as to the actual material question at issue – whether or not the condition precedent had been met (it had not). The court also affirmed dismissal of the landlord’s tortious interference with contract claim against MSHS, for failure to raise a triable issue of fact that the lease had actually been breached. 

AEL are accomplished commercial and appellate counsel who have achieved victory for clients in myriad business litigations and disputes. We are proud to have obtained victories for our great clients MHSH, SNCH, and SNMG in this matter, and look forward to helping our clients achieve success in commercial disputes and appellate matters in the future. You can read more about our commercial litigation practice here.

Categories
news

AEL Partner Ken Abell Selected Among 10 Most Inspiring Lawyers by Inc Magazine

For its June 2022 issue, Inc. Magazine selected AEL partner Ken Abell as among its 10 Most Inspiring Lawyers to Watch and interviewed Ken about AEL’s meteoric rise in the New York boutique law firm market. The article noted that AEL is one of the only small law firms offering representation in high-stakes government investigations and False Claims Act (FCA) matters, a market typically left to “BigLaw.” Already recognized by ChambersUSA for its highly personalized, responsive and cost-efficient business model, Inc Magazine also noted AEL’s distinctive brand:

The team at AEL becomes personally invested in every one of their cases and is dedicated to achieving the best possible results for their clients. On a daily basis, the AEL team can be found in the trenches with their clients, fighting for their interests and well-being.

You can read the entire article and interview here.